Dr. Jeffrey Cummings, a world-renowned Alzheimer’s researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. The prize, awarded by the Alzheimer’s Drug Discovery Foundation (ADDF), recognizes leading researchers developing treatments for Alzheimer’s disease and related dementias.
The Melvin R. Goodes Prize includes a $150,000 award and will support Dr. Cummings’ research into rasagiline, an FDA-approved Parkinson’s drug that has been shown to improve cognition and holds promise for slowing the progression of Alzheimer’s disease.
Dr. Cummings is a neurologist and clinical trialist involved in the development of new therapies for Alzheimer’s disease and related neurodegenerative disorders. He is Research Professor of the Department of Brain Health at…
